BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1228 related articles for article (PubMed ID: 8877711)

  • 61. The prognostic role of detection of circulating melanoma cells in the blood.
    Dutcher JP
    J Clin Oncol; 2003 Mar; 21(5):757-9. PubMed ID: 12610168
    [No Abstract]   [Full Text] [Related]  

  • 62. Detection of melanoma cells in bone marrow using monoclonal antibodies. A comparison of fluorescence activated cell sorting (FACS) and conventional immunofluorescence (IF).
    Dantas ME; Brown JP; Thomas MR; Robinson WA; Glode LM
    Cancer; 1983 Sep; 52(6):949-53. PubMed ID: 6349783
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Minimal residual disease - detection possibilities in haematological and non-haematological malignancies].
    Kalinová M
    Cesk Patol; 2013 Oct; 49(4):131-8. PubMed ID: 24289483
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Disseminated tumor cells: diagnosis, prognostic relevance, phenotyping and therapeutic strategies].
    Pantel K; von Knebel Doeberitz M; Izbicki JR; Riethmüller G
    Chirurg; 1997 Dec; 68(12):1241-50. PubMed ID: 9483347
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Technical aspects of minimal residual disease detection in carcinoma patients.
    Lacroix J; Doeberitz MK
    Semin Surg Oncol; 2001 Jun; 20(4):252-64. PubMed ID: 11747266
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neuroblastoma cells circulate in peripheral blood.
    Lanino E; Melodia A; Casalaro A; Cornaglia-Ferraris P
    Pediatr Hematol Oncol; 1989; 6(2):193-5. PubMed ID: 2702074
    [No Abstract]   [Full Text] [Related]  

  • 67. Molecular characterization of minimal residual cancer cells in patients with solid tumors.
    Böckmann B; Grill HJ; Giesing M
    Biomol Eng; 2001 Mar; 17(3):95-111. PubMed ID: 11222984
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Biochemical and immunologic diagnosis of cancer. Melanoma.
    Cordon-Cardo C
    Tumour Biol; 1987; 8(2-3):151-5. PubMed ID: 3329398
    [No Abstract]   [Full Text] [Related]  

  • 69. Beyond hematoxylin and eosin--the role of immunohistochemistry in surgical pathology.
    Jaffer S; Bleiweiss IJ
    Cancer Invest; 2004; 22(3):445-65. PubMed ID: 15493365
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Detection of tumor cells in bone marrow, peripheral blood and lymph nodes by automated imaging devices.
    Mesker WE; Vrolijk H; Sloos WC; Tollenaar RA; Tanke HJ
    Cell Oncol; 2006; 28(4):141-50. PubMed ID: 16988469
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Detection and clinical relevance of micrometastatic cancer cells.
    Pantel K; von Knebel Doeberitz M
    Curr Opin Oncol; 2000 Jan; 12(1):95-101. PubMed ID: 10687736
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Melanoma-associated antigens.
    Carrel S; Rimoldi D
    Eur J Cancer; 1993; 29A(13):1903-7. PubMed ID: 8260252
    [No Abstract]   [Full Text] [Related]  

  • 73. Biological characteristics of micrometastatic carcinoma cells in bone marrow.
    Braun S; Pantel K
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 1)():163-77. PubMed ID: 8814985
    [No Abstract]   [Full Text] [Related]  

  • 74. Clinical relevance of minimal residual cancer in patients with solid malignancies.
    Moss TJ
    Cancer Metastasis Rev; 1999; 18(1):91-100. PubMed ID: 10505548
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers.
    Riethmüller G; Johnson JP
    Curr Opin Immunol; 1992 Oct; 4(5):647-55. PubMed ID: 1418733
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Elimination of carcinoma cells from human bone marrow.
    Buckman R; McIlhinney RA; Shepherd V; Patel S; Coombes RC; Neville AM
    Lancet; 1982 Dec; 2(8313):1428-30. PubMed ID: 6129508
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular diagnosis of circulating cancer cells using MAGE gene assays.
    Mori M; Mimori K; Tanaka F; Ueo H; Sugimachi K; Akiyoshi T
    JAMA; 1997 Aug; 278(6):476-7. PubMed ID: 9256218
    [No Abstract]   [Full Text] [Related]  

  • 78. Diagnosis of digestive tract cancer using cDNA probe and monoclonal antibody.
    Imai K
    Jpn J Med; 1990; 29(6):659-61. PubMed ID: 2101420
    [No Abstract]   [Full Text] [Related]  

  • 79. Biochemical and immunologic diagnosis of cancer. Molecular probes and tumors in general.
    Sikora K
    Tumour Biol; 1987; 8(2-3):166-9. PubMed ID: 3329401
    [No Abstract]   [Full Text] [Related]  

  • 80. Micrometastasis detection and treatment with monoclonal antibodies.
    Pantel K; Riethmüller G
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():1-18. PubMed ID: 8814999
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.